{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:56:42Z","timestamp":1790539002959,"version":"4.1.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201200003I\/HHSN27200023"],"award-info":[{"award-number":["HHSN272201200003I\/HHSN27200023"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201200003I\/HHSN27200001"],"award-info":[{"award-number":["HHSN272201200003I\/HHSN27200001"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Southwest National Primate Research Center, Emory University","award":["P51 OD011133"],"award-info":[{"award-number":["P51 OD011133"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>\n                    Filoviruses (Family\n                    <jats:italic>Filoviridae<\/jats:italic>\n                    genera\n                    <jats:italic>Ebolavirus<\/jats:italic>\n                    and\n                    <jats:italic>Marburgvirus<\/jats:italic>\n                    ) are negative-stranded RNA viruses that cause severe health effects in humans and non-human primates, including death. Except in outbreak settings, vaccines and other medical countermeasures against Ebola virus (EBOV) will require testing under the FDA Animal Rule. Multiple vaccine candidates have been evaluated using cynomolgus monkeys (CM) exposed to EBOV Kikwit strain. To the best of our knowledge, however, animal model development data supporting the use of CM in vaccine research have not been submitted to the FDA. This study describes a large CM database (122 CM, 62 female and 60 male, age 2 to 9 years) and demonstrates the consistency of the CM model through time to death models and descriptive statistics. CMs were exposed to EBOV doses of 0.1 to 100,000 PFU in 33 studies conducted at three Animal Biosafety Level 4 facilities, by three exposure routes. Time to death was modeled using Cox proportional hazards models with a frailty term that incorporated study-to-study variability. Despite significant differences attributed to exposure variables, all CMs exposed to the 100 to 1,000 pfu doses commonly used in vaccine studies died or met euthanasia criteria within 21 days of exposure, median 7 days, 93% between 5 and 12 days of exposure. Moderate clinical signs were observed 4 to 5 days after exposure and preceded death or euthanasia by approximately one day. Viremia was detected within a few days of infection. Hematology indices were indicative of viremia and the propensity for hemorrhage with progression of Ebola viremia. Changes associated with coagulation parameters and platelets were consistent with coagulation disruption. Changes in leukocyte profiles were indicative of an acute inflammatory response. Increased liver enzymes were observed shortly after exposure. Taken together, these factors suggest that the cynomolgus monkey is a reliable animal model for human disease.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0252874","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T13:29:51Z","timestamp":1625232591000},"page":"e0252874","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus disease"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5166-7743","authenticated-orcid":true,"given":"Nancy A.","family":"Niemuth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Fallacara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl A.","family":"Triplett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay M.","family":"Tamrakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha","family":"Rajbhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint","family":"Florence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Carrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yenny","family":"Goez-Gazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6031-5360","authenticated-orcid":true,"given":"Kendra J.","family":"Alfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary M.","family":"Staples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Brasel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason E.","family":"Comer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Massey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanon","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kocsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Lowry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara C.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8581-7535","authenticated-orcid":true,"given":"Aysegul","family":"Nalca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur J.","family":"Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Shurtleff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0080-3260","authenticated-orcid":true,"given":"Margaret L.","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Trefry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"issue":"3","key":"pone.0252874.ref001","first-page":"4","article-title":"Overview, Control Strategies, and Lessons Learned in the CDC Response to the 2014\u20132016 Ebola Epidemic.","volume":"65","author":"BP Bell","year":"2016","journal-title":"Morbidity & Mortality Weekly Report. Suppl"},{"key":"pone.0252874.ref002","unstructured":"Centers for Disease Control [Internet]. 2014\u20132016 Ebola Outbreak in West Africa. Available from: https:\/\/www.cdc.gov\/vhf\/ebola\/history\/2014-2016-outbreak\/index.html"},{"key":"pone.0252874.ref003","unstructured":"World Health Organization [Internet]. Ebola in the Democratic Republic of the Congo\u2013North Kivu, Ituri 2018\u20132020. Available from: https:\/\/www.who.int\/emergencies\/diseases\/ebola\/drc-2019"},{"key":"pone.0252874.ref004","unstructured":"World Health Organization [Internet]. Ebola in the Democratic Republic of the Congo 2020 \u2013\u00c9quateur Province. Available from: https:\/\/www.who.int\/emergencies\/diseases\/ebola\/ebola-health-update\u2014%C3%A9quateur-province-democratic-republic-of-the-congo-2020"},{"key":"pone.0252874.ref005","unstructured":"World Health Organization [Internet]. Ebola outbreak in western Democratic Republic of the Congo reaches 100 cases. Available from: https:\/\/www.afro.who.int\/news\/ebola-outbreak-western-democratic-republic-congo-reaches-100-cases"},{"key":"pone.0252874.ref006","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(18)31710-0","article-title":"Prevention of Ebola virus disease through vaccination: where we are in 2018","volume":"392","author":"Y Levy","year":"2018","journal-title":"Lancet"},{"key":"pone.0252874.ref007","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.","volume":"381","author":"S Mulangu","year":"2019","journal-title":"New England journal of medicine"},{"key":"pone.0252874.ref008","unstructured":"European Medicines Agency [Internet]. Ervebo. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/ervebo"},{"key":"pone.0252874.ref009","unstructured":"Food and Drug Administration [Internet]. ERVEBO. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/ervebo"},{"key":"pone.0252874.ref010","unstructured":"European Medicines Agency [Internet]. Zabdeno. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/zabdeno"},{"key":"pone.0252874.ref011","unstructured":"European Medicines Agency [Internet]. Mvabea. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/mvabea"},{"key":"pone.0252874.ref012","article-title":"Guidance for Industry: Product Development Under the Animal Rule","author":"Food and Drug Administration, Center for Drug Evaluation and Research\/Center for Biologics Evaluation and Research [Internet]","year":"2015"},{"key":"pone.0252874.ref013","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijid.2018.06.022","article-title":"Ebola vaccine development: Systematic review of pre-clinical and clinical studies, and meta-analysis of determinants of antibody response variability after vaccination","volume":"74","author":"L Gross","year":"2018","journal-title":"International journal of infectious diseases"},{"issue":"6","key":"pone.0252874.ref014","doi-asserted-by":"crossref","first-page":"774","DOI":"10.30802\/AALAS-JAALAS-19-000007","article-title":"Effects of Transportation and Relocation on Immunologic Measures in Cynomolgus Macaques (Macaca fascicularis).","volume":"58","author":"KA Shelton","year":"2019","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"pone.0252874.ref015","unstructured":"UK National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [Internet]. The Macaque Website. Available from: https:\/\/www.nc3rs.org.uk\/macaques\/macaques\/life-history-and-diet\/"},{"issue":"3","key":"pone.0252874.ref016","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/jmp.12043","article-title":"The genetic composition of populations of cynomolgus macaques (Macaca fascicularis) used in biomedical research","volume":"42","author":"S Kanthaswamy","year":"2013","journal-title":"Journal of medical primatology"},{"key":"pone.0252874.ref017","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/viro.1995.0052","article-title":"GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases","volume":"214","author":"VE Volchkov","year":"1995","journal-title":"Virology"},{"issue":"11","key":"pone.0252874.ref018","doi-asserted-by":"crossref","first-page":"e50316","DOI":"10.1371\/journal.pone.0050316","article-title":"Ebola virus genome plasticity as a marker of its passaging history: A comparison of in vitro passaging to non-human primate infection","volume":"7","author":"JR Kugelman","year":"2012","journal-title":"PLOS ONE"},{"key":"pone.0252874.ref019","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.3390\/v7122969","article-title":"Ebola virus infections in nonhuman primates are temporally influenced by glycoprotein poly-u editing site populations in the exposure material.","volume":"7","author":"JC Trefry","year":"2015","journal-title":"Viruses"},{"issue":"5","key":"pone.0252874.ref020","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/JVI.02701-15","article-title":"Determination and Therapeutic Exploitation of Ebola Virus Spontaneous Mutation Frequency","volume":"90","author":"KJ Alfson","year":"2016","journal-title":"Journal of Virology"},{"issue":"16","key":"pone.0252874.ref021","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1002\/sim.6905","article-title":"Finite sample pointwise confidence intervals for a survival distribution with right\u2010censored data","volume":"35","author":"MP Fay","year":"2016","journal-title":"Statistics in medicine"},{"key":"pone.0252874.ref022","author":"TM Therneau","year":"2000"},{"key":"pone.0252874.ref023","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.bjc.6601119","article-title":"Survival Analysis Part II: Multivariate data analysis\u2013an introduction to concepts and methods","volume":"89","author":"MJ Bradburn","year":"2003","journal-title":"British journal of cancer"},{"key":"pone.0252874.ref024","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-31245-3","volume-title":"Applied survival analysis using R","author":"D Moore","year":"2016"},{"key":"pone.0252874.ref025","first-page":"287","author":"K Hrapkiewicz","year":"2007"},{"issue":"2","key":"pone.0252874.ref026","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5625\/lar.2016.32.2.79","article-title":"Reference values of clinical pathology parameters in cynomolgus monkeys (Macaca fascicularis) used in preclinical studies","volume":"32","author":"H Park","year":"2016","journal-title":"Lab animal research."},{"key":"pone.0252874.ref027","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1242\/dmm.000471","article-title":"Disease modeling for Ebola and Marburg viruses","volume":"2","author":"D Bente","year":"2009","journal-title":"Dis Mod Mech"},{"key":"pone.0252874.ref028","first-page":"1409","volume-title":"Fields Virology","author":"A Sanchez","edition":"5"},{"key":"pone.0252874.ref029","unstructured":"National Institutes of Health, National Institute for Allergy and Infectious Diseases. [Internet]. NIAID Emerging Infectious Diseases\/ Pathogens. Available from: https:\/\/www.niaid.nih.gov\/research\/emerging-infectious-diseases-pathogens"},{"issue":"2","key":"pone.0252874.ref030","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MTBP-0003-2016","article-title":"Transmission, human population, and pathogenicity: the Ebola case in point","volume":"6","author":"R Delgado","year":"2018","journal-title":"Microbiol spectrum."},{"key":"pone.0252874.ref031","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/7422","article-title":"Defective humoral responses and extensive intravascular apoptosis are associate with fatal outcome in Ebola virus-infected patients","volume":"5","author":"S Baize","year":"1999","journal-title":"Nature medicine"},{"issue":"8","key":"pone.0252874.ref032","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1128\/JVI.78.8.4330-4341.2004","article-title":"Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome","volume":"78","author":"JS Towner","year":"2004","journal-title":"Journal of virology"},{"key":"pone.0252874.ref033","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrmicro2129","article-title":"Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule.","volume":"7","author":"NJ Sullivan","year":"2009","journal-title":"Nature reviews microbiology"},{"issue":"12","key":"pone.0252874.ref034","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1172\/JCI83162","article-title":"Ebola viral load at diagnosis associates with patient outcome and outbreak evolution","volume":"125","author":"M de la Vega","year":"2015","journal-title":"Journal of clinical investigation"},{"issue":"12","key":"pone.0252874.ref035","first-page":"4692","article-title":"Blood kinetics of Ebola virus in survivors and nonsurvivors","volume":"125","author":"S Lanini","year":"2015","journal-title":"Clin Med"},{"issue":"138","key":"pone.0252874.ref036","first-page":"138ra81","article-title":"Successful treatment of Ebola-virus-infected cynomolgus macaques with monoclonal antibodies","volume":"4","author":"X Qui","year":"2012","journal-title":"Science translational medicine"},{"key":"pone.0252874.ref037","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(83)91041-3","article-title":"Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management","volume":"2","author":"SP Fisher-Hoch","year":"1983","journal-title":"Lancet"},{"key":"pone.0252874.ref038","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1099\/0022-1317-82-6-1365","article-title":"The role of the Type I interferon response in the resistance of mice to filovirus infection","volume":"82","author":"M Bray","year":"2001","journal-title":"J. Gen. Virol"},{"key":"pone.0252874.ref039","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection","volume":"163","author":"TW Geisbert","year":"2003","journal-title":"Am J Pathol"},{"issue":"10","key":"pone.0252874.ref040","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/v10100513","article-title":"Ebola virus causes intestinal tract architectural disruption and bacterial invasion in non-human primates","volume":"10","author":"RB Reisler","year":"2018","journal-title":"Viruses"},{"issue":"8B","key":"pone.0252874.ref041","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/clinchem\/46.8.1260","article-title":"Coagulation and bleeding disorders: review and update","volume":"46","author":"D Triplett","year":"2000","journal-title":"Clin Chem"},{"key":"pone.0252874.ref042","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/infdis\/152.5.887","article-title":"Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola).","volume":"152","author":"SP Fisher-Hoch","year":"1985","journal-title":"J Infect Dis"},{"key":"pone.0252874.ref043","author":"JW Linman","year":"1975"},{"key":"pone.0252874.ref044","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"H Feldmann","year":"2010","journal-title":"Lancet"},{"key":"pone.0252874.ref045","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4049\/jimmunol.1700827","article-title":"Ebola immunity: gaining a winning position in lightning chess","volume":"201","author":"A Ploquin","year":"2018","journal-title":"Journal of immunology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252874","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T13:30:46Z","timestamp":1625232646000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252874"}},"subtitle":[],"editor":[{"given":"Pierre","family":"Roques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0252874","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,2]]}}}